5 amino 1mq nnmt inhibitor adiposity study Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice 5-Amino-1MQ Research Grade NNMT Inhibitor

Eligibility & Dose Requirements Proof of your current prescription and dosage is required during your consultation. Your provider will verify your eligibility and determine the appropriate dose based on your treatment history. To qualify for 4.4mg/week, you must have been prescribed at least 2.2mg/week within the past 45 days. To qualify for 7mg/week, you must have been prescribed at least 4.4mg/week within the past 45 days. To qualify for 10mg/week, you must have been prescribed at least 7mg/week within the past 45 days. Patients requesting 13mg/week must have documentation of prior treatment at an appropriate dose, as determined by the prescribing provider

Some mild side effects may occur, such as redness at the injection site or slight nausea

Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice

Inject subcutaneously or intramuscularly